You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
新股暗盤 | 和黃醫藥(0013.HK)暗盤段大漲逾24%
格隆匯 06-29 16:32
格隆匯6月29日丨和黃醫藥(0013.HK)暗盤段現報49.8港元,較發行價40.1港元漲24.19%。公司專注於發現、開發及商業化治療癌症及免疫性疾病的靶向療法及免疫療法,2018年至2020年收益分別為2.14億、2.04億、2.27億美元,每股有形資產淨值9.86港元。此次上市全球發售1.04億股,其中香港發售1300萬股,國際發售9100萬股,每手500股,一手中籤率60%,香港發售股份獲5.23倍認購,淨籌39.50億港元,當中約50%將用於推進公司賽沃替尼、索凡替尼、呋喹替尼、HMPL-689及HMPL-523的後期臨牀計劃以進行註冊試驗及潛在提交NDA申請。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account